Quantcast

Latest Regenerative medicine Stories

2014-08-22 23:05:03

Cryo-Cell International, Inc., the world’s first cord blood bank, announced today that it has provided funding to complete an Investigational New Drug Application (IND) for a FDA approved Phase I clinical trial for patients that have amyotrophic lateral sclerosis (ALS or Lou Gehrig's) disease using umbilical cord blood cells. Oldsmar, FL (PRWEB) August 22, 2014 This funding was made through an additional investment in Cryo-Cell’s cell therapy research affiliate, Saneron CCEL...

2014-08-21 08:29:07

SAN DIEGO, Aug. 21, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company announced today that it has entered into a Rights Agreement with Janssen Research & Development LLC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement provides Janssen with a future right to evaluate a transaction related to the VC-01(TM) combination product that ViaCyte is developing for type 1 diabetes. This right will continue...

2014-08-19 08:30:47

Company Plans to Immediately Initiate Phase 1/2 Clinical Trial SAN DIEGO, Aug. 19, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, announced today that the U.S. Food and Drug Administration ("FDA") has accepted the company's Investigational New Drug Application ("IND") for its VC-01(TM) candidate cell replacement therapy to treat type 1 diabetes. The company plans to promptly initiate a Phase 1/2 clinical trial which it believes to be the first...

2014-08-14 16:26:32

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the Global Regenerative Medicine (Stem Cell Therapy, Biomaterial and Tissue Engineering) Market (Bone and Joint) - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage,...

2014-08-14 12:27:58

Computer algorithm also provides 'quality assurance' for lab-created cells BOSTON, Aug. 14, 2014 /PRNewswire-USNewswire/ -- In a boon to stem cell research and regenerative medicine, scientists at Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a "roadmap" for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable...

2014-08-08 12:25:15

SAN DIEGO, Aug. 8, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, announced today that it has completed a private equity financing transaction, providing the Company with $5.4 million through the sale of Series C-1 Preferred Stock, together with warrants to purchase common stock. The first closing of the Series C-1 financing occurred in July 2013. This...

2014-08-07 12:28:21

DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Regenerative Medicine Market in the US 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Regenerative Medicine market in the US has witnessed a number of mergers and acquisitions by leading vendors in the past few years. Vendors are focusing on mergers and acquisitions to strengthen their global position and increase their commercial capabilities. For...

2014-08-07 12:28:05

BOCA RATON, Fla., Aug. 7, 2014 /PRNewswire/ -- Akron is pleased to announce that it secured a strategic collaboration with Vivex Biomedical, Inc. on the use of its next-generation line of cryopreservation media, CryoNovo(TM). Vivex Biomedical, Inc., from Marietta, GA, designs and develops innovative biologic products for regenerative medicine applications. Tracy Anderson, Vivex CEO, speaks to the imperative, "Vivex underscores its commitment to patient care in the confidence that...

2014-08-04 12:33:13

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Regenerative Medicine Market in the US 2014-2018 http://www.reportbuyer.com/pharma_healthcare/healthcare/regenerative_medicine_market_us_2012_2016.html About Regenerative MedicineRegenerative medicine is the branch of medicine which uses therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. This branch of medicine focuses on repairing,...

2014-07-31 23:21:06

The Adult Stem Cell Technology Center, LLC in Boston Massachusetts has more adult stem cell intellectual property than it requires for its own current business development plans. To get its additional adult stem cell technologies into greater practice, the company recently launched a social media marketing campaign. Boston, MA (PRWEB) July 31, 2014 Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) finds itself flush with innovative adult stem cell biotechnologies. Currently the...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related